ArticleAmerican journal of cancer research2018

Everolimus following 5-aza-2-deoxycytidine is a promising therapy in paclitaxel-resistant clear cell carcinoma of the ovary.

Chih-Ming Ho et al.PubMed ↗Full text ↗

No numbers read from the abstract.